Like a learning curve FDA knows the company and the prior work performed like an audit!
12-22-21 As previously disclosed, UHP's PMA application is currently in Substantive Review by the FDA. Receipt of a PMA is a condition to the company's ability to market its HemoStyp products for human surgical procedures in the United States. Approval within 45 days! $5-$10++